Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Auger

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Potent Class of PI3Kα Inhibitors with Unique Binding Mode via Encoded Library Technology (ELT)Hongfang Yang, Patricia F Medeiros, Kaushik Raha, et al.
Nature|October 4, 2011
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaMark A Dawson, Rab K Prinjha, Antje Dittmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 23, 2021
Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLTMarc de Perrot, Deepa Gopalan, David Jenkins, et al.
The European Respiratory Journal|January 19, 2019
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertensionMichael Newnham, Kieron South, Marta Bleda, et al.
Journal of Medicinal Chemistry|August 30, 2007
Novel ATP-competitive kinesin spindle protein inhibitorsCynthia A Parrish, Nicholas D Adams, Kurt R Auger, et al.
The Lancet. Haematology|September 2, 2022
Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendationAdam M Gwozdz, Cindy M M de Jong, Luz Sousa Fialho, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of RapamycinSteven D Knight, Nicholas D Adams, Joelle L Burgess, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295Xiangping Qian, Andrew McDonald, Han-Jie Zhou, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Potent Class of PI3Kα Inhibitors with Unique Binding Mode via Encoded Library Technology (ELT)Hongfang Yang, Patricia F Medeiros, Kaushik Raha, et al.
Nature|October 4, 2011
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaMark A Dawson, Rab K Prinjha, Antje Dittmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 23, 2021
Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLTMarc de Perrot, Deepa Gopalan, David Jenkins, et al.
The European Respiratory Journal|January 19, 2019
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertensionMichael Newnham, Kieron South, Marta Bleda, et al.
Journal of Medicinal Chemistry|August 30, 2007
Novel ATP-competitive kinesin spindle protein inhibitorsCynthia A Parrish, Nicholas D Adams, Kurt R Auger, et al.
The Lancet. Haematology|September 2, 2022
Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendationAdam M Gwozdz, Cindy M M de Jong, Luz Sousa Fialho, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of RapamycinSteven D Knight, Nicholas D Adams, Joelle L Burgess, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295Xiangping Qian, Andrew McDonald, Han-Jie Zhou, et al.
Pageof 17